Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease

The most common chronic liver illness worldwide is metabolic dysfunction linked to fatty liver disease (MAFLD), which is poorly understood by doctors and patients. Many people with this disease develop steatohepatitis, cirrhosis and its consequences, as well as extrahepatic manifestations; these con...

Full description

Saved in:
Bibliographic Details
Published in:Hepatology international 2024-10, Vol.18 (Suppl 2), p.827-833
Main Authors: Fouad, Yasser, Alboraie, Mohamed, Shiha, Gamal
Format: Article
Language:English
Subjects:
Biopsy
Cirrhosis
Colorectal Surgery
Diabetes mellitus
Diagnosis
Epidemiology
Fatty liver
Fatty Liver - diagnosis
Fatty Liver - epidemiology
Fatty Liver - etiology
Fibrosis
Hepatology
Humans
Liver
Liver - metabolism
Liver - pathology
Liver Cirrhosis - diagnosis
Liver Cirrhosis - epidemiology
Liver Cirrhosis - metabolism
Liver diseases
Medicine
Medicine & Public Health
Non-alcoholic Fatty Liver Disease - diagnosis
Non-alcoholic Fatty Liver Disease - epidemiology
Non-alcoholic Fatty Liver Disease - metabolism
Obesity - complications
Obesity - epidemiology
Special supplement : MAFLD
Steatosis
Surgery
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The most common chronic liver illness worldwide is metabolic dysfunction linked to fatty liver disease (MAFLD), which is poorly understood by doctors and patients. Many people with this disease develop steatohepatitis, cirrhosis and its consequences, as well as extrahepatic manifestations; these conditions are particularly common if they are linked to diabetes mellitus or obesity. A breakthrough with numerous benefits is the switch from NAFLD to MAFLD in terms of terminology and methodology. The diagnosis of MAFLD is based on affirmative criteria; unlike NAFLD, it is no longer based on exclusion. The diagnosis of MAFLD and the evaluation of steatosis and fibrosis is achieved using liver biopsy and non-invasive laboratory or radiographic techniques. We briefly address the most recent developments in MAFLD epidemiology and diagnosis.
ISSN:1936-0533
1936-0541
1936-0541
DOI:10.1007/s12072-024-10704-3